The challenges of switching to improved first-line HIV/AIDS treatments

MSFAccessCampaign on April 11, 2011 14:57

Play
0.00 / 3.19
Hide the comments

Stats for this track

This Week Total
Plays 47
Favoritings 1

Uploaded by

  • Report copyright infringement

    More tracks by MSFAccessCampaign

    "Doctors push for funding as AIDS epidemic reaches turning point" - World Radio Switzerland

    A New Vaccine in the Long Battle Against Malaria - Excerpt from "The Takeaway"

    Giving the Right Foods in a Nutrition Crisis - MSF Frontline Reports

    Children With HIV Need More Treatment Options; DNDi Aims to Help Fill The Void

    May 2008: Podcast from World Health Assembly

    View all

    The most commonly used first-line AIDS treatment in developing countries includes the drug stavudine, also known as d4t. This drug can cause a variety of side-effects in patients, including neuropathy and lipoatrophy, which means that patients need to be taken off the drug. A study carried out in MSF’s HIV project in Kigali, Rwanda, and presented at the IAC in Mexico City in August 2008 showed that 16.6% of patients needed to switch to an alternative regimen due to the side effects related to stavudine.

    This is just one of the challenges facing doctors and patients in treatment for HIV/AIDS.

    Add a new comment

    You need to be logged in to post a comment. If you're already a member, please or sign up for a free account.

    Share to WordPress.com

    If you are using self-hosted WordPress, please use our standard embed code or install the plugin to use shortcodes.
    Add a comment 0 comments at 0.00
      Click to enter a
      comment at
      0.00